COMP <GO>
INNV vs OMDA // EV/EBITDA & P/E VALUATION
InnovAge Holding Corp. (NASDAQ) VS. Omada Health Inc. (NASDAQ) • 15-METRIC TALLY: INNV 6
— OMDA 4
■ METRIC PARITY
LAST: $9.24 (+1.54%) • MKT CAP: $1.26B
valuation
—
LAST: $19.65 (+2.45%) • MKT CAP: $1.20B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INNV VS. OMDA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INNV | OMDA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 18.00% | 65.70% | -47.70 | OMDA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -10.20% | -15.70% | +5.50 | INNV | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.11% | 1.41% | +0.70 | INNV | /fcf-yield <GO> |
| Operating Margin | -3.50% | -4.60% | +1.10 | INNV | /operating-margins <GO> |
| Net Profit Margin | -3.60% | -4.90% | +1.30 | INNV | /net-margins <GO> |
| Revenue Growth (YoY) | 11.80% | 53.20% | -41.40 | OMDA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.47 | 8.93 | -4.46 | OMDA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | OMDA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.7 | 43.6 | +2.16 | INNV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.26B | $1.20B | $57.9M | INNV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INNV REV | OMDA REV | INNV GROSS % | OMDA GROSS % | INNV FCF | OMDA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $853.7M | $260.2M | 18.0% | 65.7% | $26.6M | $16.9M |
| FY 2024 | $763.9M | $169.8M | 17.3% | 60.6% | -$44.8M | -$34.8M |
| FY 2023 | $688.1M | $122.8M | — | — | $20.2M | -$49.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INNV // BETA —
OMDA // BETA —